Ravasio, R., S. Antonelli, A. Maiorino, A. Costanzo, and S. Losi. “Cost Per Responder for Ixekizumab and Other Biologic Drugs Approved for the Treatment of Moderate-to-Severe Plaque Psoriasis in Italy”. Global and Regional Health Technology Assessment, vol. 6, no. 1, Jan. 2019, doi:10.33393/grhta.2019.468.